Alkosign Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve 1. Unaudited Standalone and Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkosign Ltd has informed BSE that its Board of Directors will meet on Thursday, November 13, 2025, at the registered office in Bhiwandi, Maharashtra. The main agenda is to consider and approve the unaudited standalone and consolidated financial results for the half year ended September 30, 2025. The company has also confirmed that the trading window for dealing in its equity shares has been closed since October 1, 2025, and will reopen 48 hours after the financial results are published. This is a standard regulatory intimation under SEBI Listing Regulations, and no actual financial numbers have been disclosed in this filing.
This is a routine pre-results announcement with no direct impact on the stock. Investors should watch for the actual H1 FY26 results on November 13, which will reveal the company's revenue, profitability, and margins for the period.